New data suggest that the United States launches the most new cancer drugs of any other country and is most likely to launch cancer drugs first.

High-compensation surgical specialties experienced increase in the proportion of female applicants and matriculants from 2008 to 2022 ...

(HealthDay News) — For men receiving androgen deprivation therapy (ADT) for prostate cancer, time to testosterone recovery (TR) varies with ADT duration, according to a study published online in ...

Robot-assisted partial nephrectomy and image-guided percutaneous cryoablation for renal cell carcinoma (cT1) offer similar outcomes.

Incidence rates of cardiovascular disease were higher in older adults with cancer after treatment compared with those without cancer.

Despite a prolific number of studies of the dysregulation of these minerals in CKD and the potential interventions to bring them back into a normal range, outcomes are uncertain and some of these ...

LUGPA contends that current CMS payment policies endanger access to urologic care and threaten revenue loss for urologists.

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

In patients with vs without history of incident heart failure hospitalization there is more rapid decline in global cognition.

The CDC is warning the public about the potential for receiving counterfeit medications through unverified online pharmacies.

Risk for thrombotic events higher in individuals with non-O blood types to a greater extent than those with blood type O ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.